Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sequestration Threat Looms For 2013 Health Care Spending

This article was originally published in The Gray Sheet

Executive Summary

A report from Sen. Tom Harkin states that impending across-the-board cuts would lead to major NIH grants reduction, in addition to significant spending cuts for cancer and HIV screening.

You may also be interested in...



Friendly Fire? Tavenner Nomination Held Up By Sen. Harkin

While the Senate Finance Committee April 23 agreed to endorse Marilyn Tavenner to head CMS, Sen. Tom Harkin, D-Iowa, Chairman of the Senate HELP Committee, put a block on her full Senate approval the next day.

Congress Set To Pass Six-Month Funding Bill, As Sequestration Still Looms

Both the pending continuing resolution legislation and the sequestration have potential implications, not only for the funding FDA receives from Congress, but also for contributions from industry user fees.

Regulatory News In Brief

FDA tells small businesses how to qualify for discounted user fees. Agency plans September conference for industry on unique device identification proposed rule. More regulatory news.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel